Practical, step-by-step guides for anyone starting or managing GLP-1 treatment. Learn how to begin safely, what to expect week by week, and how to get the most from your medication with confidence.
Patient Guides
A Florida State University researcher has found that people using GLP-1 medications like semaglutide and tirzepatide often face unexpected stigma from their own social circles. This article breaks down why that stigma happens, how it affects treatment outcomes, and what you can do to protect your mental health while staying on track with your medication.
In 2026, FDA approved GLP-1 pills start at about $149 a month through manufacturer self pay programs. This guide explains what $150 buys, how prices rise at maintenance doses, current compounding rules and safety data, insurance and Medicare options, and questions to ask any low cost program.
A 2026 Pediatrics study found GLP-1 prescribing for children aged 8 to 11 with obesity rose about 310 fold since 2019, though only 0.6% received one. This guide explains which GLP-1s are approved for children, STEP TEENS results, safety monitoring, costs, and how families can access specialist care.
Many insurance plans cover GLP-1 medications only after patients develop diabetes or heart disease, even though these drugs lower the risk of both. This article explains coverage rules, the 2026 Medicare GLP-1 Bridge, current self pay prices, and how to appeal a denial.
More patients combine GLP-1 medications with chiropractic care, yet their providers rarely coordinate. This guide explains how weight loss, muscle loss, bone health, and side effects affect chiropractic treatment, and what to tell your chiropractor and your prescriber.
Medicare's GLP-1 Bridge, running July 2026 through December 2027, offers eligible Part D enrollees a $50 monthly copay on Wegovy, Foundayo, and the Zepbound KwikPen. Strict BMI tiers apply, and people with type 2 diabetes, sleep apnea, or MASH are excluded. This guide explains who qualifies, who does not, and what to do next.
With the Wegovy pill and Foundayo now FDA approved, scammers are selling counterfeit and unapproved GLP-1 products online. This guide explains which oral GLP-1s are real, the four most common scams, red flags to watch for, and how to verify a pharmacy and lower costs safely.
GLP-1 medications like semaglutide and tirzepatide are changing how doctors treat obesity, but major clinical questions remain unanswered. This article breaks down what clinicians are debating, what it means for patients, and how to have smarter conversations with your provider.
